These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 11784613)
1. Too young to be having a heart attack. Payne MY Lancet; 2001 Dec; 358 Suppl():S64. PubMed ID: 11784613 [No Abstract] [Full Text] [Related]
2. Sitosterolaemia and heterozygous familial hypercholesterolaemia in a three year old girl: case report. Nye ER; Sutherland WH; Mortimer JG; Stringer HC N Z Med J; 1988 Jun; 101(848):418-9. PubMed ID: 3393330 [TBL] [Abstract][Full Text] [Related]
3. Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia. Noto D; Cefalù AB; Barraco G; Martino E; Fayer F; Minà M; Montali A; Arca M; Averna M; Martino F Pediatr Res; 2010 Feb; 67(2):200-4. PubMed ID: 20091938 [TBL] [Abstract][Full Text] [Related]
5. [Serum cholesterol and triglyceride levels in patients with type II hyperlipoproteinemia treated with probucol]. Markiewicz M; Rymar B; Horubała-Bielak G; Koziara Z Wiad Lek; 1984 Oct; 37(19):1489-93. PubMed ID: 6528586 [No Abstract] [Full Text] [Related]
6. Serum noncholesterol sterols in children with heterozygous familial hypercholesterolemia undergoing pravastatin therapy. Hedman M; Miettinen TA; Gylling H; Ketomäki A; Antikainen M J Pediatr; 2006 Feb; 148(2):241-6. PubMed ID: 16492436 [TBL] [Abstract][Full Text] [Related]
7. Basal plasma concentrations of plant sterols can predict LDL-C response to sitosterol in patients with familial hypercholesterolemia. Fuentes F; López-Miranda J; García A; Pérez-Martínez P; Moreno J; Cofan M; Caballero J; Paniagua JA; Ros E; Pérez-Jiménez F Eur J Clin Nutr; 2008 Apr; 62(4):495-501. PubMed ID: 17440528 [TBL] [Abstract][Full Text] [Related]
12. [Results of 6 months, therapy of familial hypercholesterolemia (hyperlipoproteinemia type II) with colestipol]. Kuŝić M; Gavrilović M; Mihajloviĉ M; Boŝković B Srp Arh Celok Lek; 1980 Sep; 108(9):875-81. PubMed ID: 7302695 [No Abstract] [Full Text] [Related]
13. A testing time for heart disease. George PM; Walmsley TA; Ikram H N Z Med J; 1992 Jul; 105(937):258-60. PubMed ID: 1620510 [No Abstract] [Full Text] [Related]
14. Removal of intravenous Intralipid in patients with familial hypercholesterolemia during inhibition of cholesterol absorption and synthesis. Ketomäki A; Gylling H; Miettinen TA Clin Chim Acta; 2004 Jun; 344(1-2):83-93. PubMed ID: 15149875 [TBL] [Abstract][Full Text] [Related]
15. [Lowering of LDL cholesterol prevents cardiovascular diseases. "Normal values" are too high--treatment time is a crucial factor]. Rudling M Lakartidningen; 2006 Oct 25-31; 103(43):3278-82. PubMed ID: 17117659 [No Abstract] [Full Text] [Related]
16. [Lipoproteins in plasma and fats in nutrition in the pathogenesis of coronary heart disease. Remarks on the causes and limits of the lipid theory]. Zöllner N; Keller C Internist (Berl); 1984 May; 25(5):261-7. PubMed ID: 6376406 [No Abstract] [Full Text] [Related]
17. [Hyperlipidemia in children and adolescents]. Koletzko B MMW Fortschr Med; 2008 Nov; 150(47):34-7. PubMed ID: 19186486 [No Abstract] [Full Text] [Related]
18. Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia. Minhas R; Humphries SE; Qureshi N; Neil HA; Heart; 2009 Apr; 95(7):584-7; discussion 587-91. PubMed ID: 19168470 [No Abstract] [Full Text] [Related]